Chinese pharma-biotech dragon rears its head
With China's pharmaceutical and biotech industries still in their formative stages, their American, European, and Japanese counterparts should make significant investments in both India and China. Why? To take advantage of a talented labor pool and create markets for their own products, according to columnist...